Literature DB >> 17038152

Atrio-ventricular synchronization by single VDD lead inserted through persistent left superior vena cava in patient with Turner's syndrome.

Pier Giorgio Golzio1, Erica Franco, Amedeo Chiribiri.   

Abstract

A 71-year-old woman with Turner's syndrome underwent pacemaker implantation for complete atrio-ventricular block. During the procedure, the persistence of left sided superior vena cava (LSVC) was observed such that the lead, through the coronary sinus, reached the right atrium. By use of stylets, we could drive the lead against the lateral atrial wall and curve it through the tricuspid valve into the right ventricle. The tip reached an apical stable position, obtaining proper stimulation values. Moreover, the VDD dipole was positioned against high lateral atrial wall, adequately sensing the atrial potential. So, we could obtain an atrial synchronous ventricular pacing with only one VDD lead.

Entities:  

Mesh:

Year:  2006        PMID: 17038152     DOI: 10.1111/j.1540-8159.2006.00513.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Discovery of a persistent left superior vena cava during pacemaker implantation.

Authors:  A M Schreve-Steensma; P H M van der Valk; J B L Ten Kate; M J M Kofflard
Journal:  Neth Heart J       Date:  2008-08       Impact factor: 2.380

2.  Permanent Pacemaker Implantation in Patients With Isolated Persistent Left Superior Vena Cava From a Right-Sided Approach: Technical Considerations and Follow-Up Outcome.

Authors:  Santosh Kumar Sinha; Amit Goel; Mahmodula Razi; Mukesh Jitendra Jha; Vikas Mishra; Puneet Aggarwaal; Ramesh Thakur; Vinay Krishna; Umeshwar Pandey; Chandra Mohan Varma
Journal:  Cardiol Res       Date:  2019-02-24

3.  Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.

Authors:  Christian Trolle; Kristian H Mortensen; Lisbeth N Pedersen; Agnethe Berglund; Henrik K Jensen; Niels H Andersen; Claus H Gravholt
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.